Lysozyme (Muramidase), Plasma
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Confirming marked increases in the granulocyte or monocyte pools as in granulocytic or monocytic leukemias, myeloproliferative disorders, and malignant histiocytosis
Following the course of therapy in cases of chronic granulocytic or chronic monocytic leukemias
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Lysozyme (Muramidase), P